Abstract:

This paper sets out to examine whether a better understanding of the problems and actual behaviour of patients could be used to improve the pharmaceutical industry's communications with the doctor. The results of recent group discussions carried out with chronic sufferers of asthma in the U.K. and France, and with arthritics in the U.K., are used to illustrate the direct and indirect influences of the patients' behaviour on the doctors' prescribing decision.